BrightSpring Health Services Inc. (BTSG) stock surged 5% in pre-market trading on Thursday, following the company's impressive fourth quarter and full-year 2024 financial results, as well as an increased guidance for fiscal 2025.
For the fourth quarter ended December 31, 2024, BrightSpring reported a 28.6% year-over-year increase in net revenue to $3.05 billion, beating analysts' expectations of $3.01 billion. The company's adjusted earnings per share of $0.22 met the consensus estimate, marking a significant improvement from $0.08 in the prior-year quarter.
BrightSpring's solid performance extended to the full year, with net revenue growing 27.6% to $11.27 billion and adjusted EBITDA rising 9.3% to $588 million compared to 2023. Excluding a one-time payment in 2023, adjusted EBITDA growth stood at an impressive 15.9%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.